Autosomal dominant cerebellar ataxias: new genes and progress towards treatments
Authors:
- 19 July 2023
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 22 (8) , 735-749
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- ATXN2 polyQ intermediate repeats are a modifier of ALS survivalNeurology, 2015
- Survival and severity in dominant cerebellar ataxiasAnnals of Clinical and Translational Neurology, 2015
- Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genesBrain, 2014
- Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6Journal of Medical Genetics, 2014
- The Global Epidemiology of Hereditary Ataxia and Spastic Paraplegia: A Systematic Review of Prevalence StudiesNeuroepidemiology, 2014
- Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline dataThe Lancet Neurology, 2013
- Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational studyOrphanet Journal of Rare Diseases, 2013
- Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyondThe Lancet Neurology, 2010
- Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSNature, 2010
- The neuropsychiatry of the cerebellum — insights from the clinicThe Cerebellum, 2007